| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 0.00 | AU$ 0.00 | AU$ 5.76M | AU$ 5.76M | AU$ 7.43M |
| Gross Profit | AU$ -146.00K | AU$ 0.00 | AU$ 3.06M | AU$ 3.06M | AU$ 7.43M |
| Operating Income | AU$ -16.35M | AU$ -19.87M | AU$ -11.86M | AU$ -25.29M | AU$ -22.77M |
| EBITDA | AU$ -16.21M | AU$ -12.00M | AU$ -9.29M | AU$ -12.15M | AU$ 551.00K |
| Net Income | AU$ -9.00M | AU$ -7.92M | AU$ -11.36M | AU$ -1.94M | AU$ -2.97M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 13.56M | AU$ 15.08M | AU$ 9.23M | AU$ 8.94M | AU$ 18.71M |
| Total Assets | AU$ 19.14M | AU$ 21.44M | AU$ 24.03M | AU$ 25.19M | AU$ 33.59M |
| Total Debt | AU$ 0.00 | AU$ 84.00K | AU$ 2.04M | AU$ 4.29M | AU$ 6.32M |
| Net Debt | AU$ -13.56M | AU$ -14.99M | AU$ -7.19M | AU$ -4.65M | AU$ -12.39M |
| Total Liabilities | AU$ 2.92M | AU$ 5.42M | AU$ 14.47M | AU$ 14.38M | AU$ 30.75M |
| Stockholders' Equity | AU$ 16.21M | AU$ 16.02M | AU$ 9.56M | AU$ 10.80M | AU$ 2.85M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -9.78M | AU$ -11.12M | AU$ -7.42M | AU$ -16.61M | AU$ 2.42M |
| Operating Cash Flow | AU$ -9.78M | AU$ -11.12M | AU$ -7.28M | AU$ -16.30M | AU$ 3.07M |
| Investing Cash Flow | AU$ -2.00K | AU$ 4.18M | AU$ -131.00K | AU$ -306.00K | AU$ -644.00K |
| Financing Cash Flow | AU$ 8.26M | AU$ 18.46M | AU$ 6.98M | AU$ 6.63M | AU$ 1.52M |
Pharmaxis Ltd (CH:UUD)
:UUD
